Platelet indices as inflammatory markers in stable COPD

I. Hlapcic (Zagreb, Croatia), M. Grdic Rajkovic (Zagreb, Croatia), A. Hulina Tomaškovic (Zagreb, Croatia), A. Somborac Bacura (Zagreb, Croatia), I. Rako (Zagreb, Croatia), A. Vukic Dugac (Zagreb, Croatia), L. Rumora (Zagreb, Croatia)

Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of asthma
Session: Novel mechanisms elucidated by translational studies of asthma
Session type: Poster Discussion
Number: 5205
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Hlapcic (Zagreb, Croatia), M. Grdic Rajkovic (Zagreb, Croatia), A. Hulina Tomaškovic (Zagreb, Croatia), A. Somborac Bacura (Zagreb, Croatia), I. Rako (Zagreb, Croatia), A. Vukic Dugac (Zagreb, Croatia), L. Rumora (Zagreb, Croatia). Platelet indices as inflammatory markers in stable COPD. 5205

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Inflammatory mediators CRP, fibrinogen and leukocyte in stable COPD patients
Source: Annual Congress 2007 - Airway regulation, provocation and monitoring I
Year: 2007


Neutrophil apoptosis and systemic inflammatory markers in acute exacerbation of COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 572s
Year: 2003

Alterations in sputum inflammatory markers during exacerbations for COPD patients with different stable state levels
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019


Coagulation markers in COPD
Source: International Congress 2018 – COPD and chronic respiratory disease: from misclassification to radiological findings
Year: 2018



Is there any correlation between blood neutrophil inflammatory biochemical markers and lung function impairment in COPD patients?
Source: Eur Respir J 2003; 22: Suppl. 45, 85s
Year: 2003

Elevated serum inflammatory markers in patients with stable COPD
Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease
Year: 2009


Platelet activation is enhanced in stable and exacerbated COPD
Source: Annual Congress 2009 - Biomarkers and biology in COPD
Year: 2009


Some local markers indices of saliva inflammation in patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 62s
Year: 2004

Platelet aggregation status in chronic obstructive pulmonary disease associated with SARS-Cov-19
Source: Virtual Congress 2021 – Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trials
Year: 2021

Differences in biomarkers of systemic inflammation in two phenotypes of COPD patients
Source: Annual Congress 2011 - COPD: human studies
Year: 2011


Variability of sputum inflammatory mediators in alpha-1-antitrypsin deficiency and usual COPD
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011

Can mean platelet volume be an inflammatory marker in acute exacerbation of chronic obstructive pulmonary disease?
Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment
Year: 2009


Inflammatory markers of atherogenesis in patients with uncontrolled severe asthma
Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases
Year: 2017


Nutritional and systemic inflammatory parameters in patients with COPD exacerbation: relation with functional parameters
Source: Eur Respir J 2005; 26: Suppl. 49, 297s
Year: 2005

Inflammatory markers in relation to cachexia in patients with COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 208s
Year: 2003

Adiponectin as a biomarker of systemic inflammatory response in stable and exacerbation phases of COPD
Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation
Year: 2008


Relationship between inflammatory mediators in induced sputum and BODE-index in patients with COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 142s
Year: 2007

Simvastatin does not reduce levels of inflammatory blood markers in patients with stable chronic obstructive pulmonary disease
Source: Annual Congress 2008 - COPD
Year: 2008


Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2018 – Biomarkers for evaluating COPD
Year: 2018

The interrelation between inflammation markers and protease-antiprotease status in blood serum in patients with stable COPD
Source: Annual Congress 2007 - Pathophysiology and assessment of COPD
Year: 2007